1. ALLA AKTIER
  2. NYHETER
  3. NEODYNAMICS

NeoDynamics

Nyheter NeoDynamics Nyheter alla bolag

Unofficial trading through Pareto Securities after delisting

MARKN.

Pareto Securities will hold OTC (unofficial) trading in NeoDynamics' stock after the company is delisted from trading on Nasdaq First North on July 30, 2024.

The assignment includes publishing buy and sell price indications on Pareto's website and on Bloomberg, facilitating trading in the share and closing trades made through Pareto's services.

Pareto provides the opportunity to trade shares online via their website, as well as manually via brokers. They note that trading in unlisted shares can involve a higher risk both through a smaller supply of information and liquidity. Unlisted shares cannot be stored in ISK, but normal custody accounts are fine. For more information regarding price when trading in unlisted shares, Pareto refers to its price list.

For more information, see the Pareto Securities webpage: Trading in unlisted shares, or contact Joakim Appeltofft via joakim.appeltofft@paretosec.com.

About NeoNavia
NeoNavia is a modern biopsy system with a completely new patented pulse technology intended for ultrasound-guided tissue sampling. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumor whilst enabling high-quality tissue samples from both breasts and lymph nodes. The pulse biopsy system NeoNavia is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment.

About NeoDynamics
NeoDynamics AB is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound-guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at leading clinics in Europe and launches in USA during 2024. NeoDynamic’s shares are listed on Nasdaq First North Growth Market Stockholm (ticker: NEOD). The company’s Certified Adviser is Redeye AB.

Attachments
Unofficial trading through Pareto Securities after delisting

Datum 2024-07-12, kl 08:59
Källa MFN
Bifogade filer
Unofficial trading through Pareto Securities after delisting
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!